FRTX · Categories · Form 4
FRTX - SEC Form 4 insider transactions
Fresh Tracks Therapeutics Inc. (FRTX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for FRTX
- SEC Form 4 filed by Fox-Collis Aaron4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
- SEC Form 4 filed by Marchio Albert N Ii4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
- Chadha Deepak converted options into 35,000 shares and covered exercise/tax liability with 14,978 shares, increasing direct ownership by 874% to 22,314 units (SEC Form 4)4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
- Fox-Collis Aaron sold $67 worth of shares (74 units at $0.91), closing all direct ownership in the company (SEC Form 4)4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
- Fox-Colis Aaron sold $31 worth of shares (36 units at $0.85), decreasing direct ownership by 33% to 74 units (SEC Form 4)4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
- Sklawer Andrew D converted options into 55,000 shares and covered exercise/tax liability with 20,833 shares, increasing direct ownership by 670% to 39,269 units (SEC Form 4)4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
- Mcavoy David R. converted options into 20,000 shares and covered exercise/tax liability with 7,358 shares, increasing direct ownership by 370% to 16,061 units (SEC Form 4)4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
- SEC Form 4 filed by Mcavoy David R.4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
- SEC Form 4 filed by Sklawer Andrew D4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
- SEC Form 4 filed by Marchio Albert N Ii4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)
- SEC Form 4 filed by Chadha Deepak4 - Fresh Tracks Therapeutics, Inc. (0000819050) (Issuer)